SEARCH HEALTH CONDITIONS BY ALPHABETS
Anemia, Chemotherapy Induced
Medications for Anemia, Chemotherapy-induced
Around Anemia, chemotherapy-induced: Anemia is an inadequate source of blood cells, resulting in a decrease within the oxygen-carrying power of the blood. A frequent reason that cancer patients experience anemia is as a side effect of chemotherapy. Anemia is important because it could worsen or trigger additional issues, like a heart disease, and could cause unwanted symptoms, such as fatigue, fatigue or shortness of breath.
Drugs Used in the Treatment of Anemia, Chemotherapy-induced
The following list of medications come used in the treatment of this particular condition, or in some way related to.
| Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Aranesp | Rx | C | N | Inch review | 10 | ||
Generic title: darbepoetin alfa systemic Medication course: recombinant human erythropoietins For customers: dosage, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Procrit | Rx | C | N | Inch review | 9.0 | ||
Generic title: epoetin alfa systemic Medication course: recombinant human erythropoietins For customers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
| epoetin alfa | Rx | C | N | Inch review | 9.0 | ||
Generic title: epoetin alfa systemic Brand names: Procrit, Epogen, Retacrit Medication course: recombinant human erythropoietins For customers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
| darbepoetin alfa | Rx | C | N | Inch review | 10 | ||
Generic title: darbepoetin alfa systemic Brand title: Aranesp Medication course: recombinant human erythropoietins For customers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph | |||||||
| Epogen | Rx | C | N | Add review | 0.0 | ||
Generic title: epoetin alfa systemic Medication course: recombinant human erythropoietins For customers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
| Retacrit | Rx | C | N | Add review | 0.0 | ||
Generic title: epoetin alfa systemic Medication course: recombinant human erythropoietins For customers: dosage, interactions, and side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Prizes | This medication might not be approved by the FDA for the treatment of this particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in pregnant women clearly outweigh potential rewards. |
| N | FDA has not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | Has a high possibility of misuse. Has no currently accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
| 2 | Has a high possibility of misuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may result in severe emotional or physical dependence. |
| 3 | features a potential for abuse less than individuals in schedules 1 and two. Features a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse relative to individuals in program 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
| 5 | Has a very low potential for abuse relative to individuals in program 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always seek advice from your physician to be sure the information pertains to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
